Advertisement

Current Concepts in Pacing 2010–2011: The Right and Wrong Way to Pace

  • Simon Modi
  • Andrew Krahn
  • Raymond Yee
Arrhythmia

Opinion statement

Over five decades have passed since the first permanent cardiac pacemakers were introduced into clinical medicine. Evolving technology and falling costs have demanded adaptation to clinical practice and implantation trends and, with the advent of evidenced-based medicine, the specific roles and benefits of individual pacemaker technologies have never been so carefully scrutinized. Pacing mode choice continues to be a subject of great controversy, and there are great regional variations in practice. We believe that single chamber atrial pacing use (AAI/R) has become an anachronism that should generally be abandoned (obviously with rare exceptional cases) and be replaced by dual chamber pacemakers (DDD/R) equipped with modern pacing algorithms that minimize patient exposure to ventricular pacing. Also, in patients with atrioventricular (AV) block, randomized clinical trials have failed to show improvement in clinically relevant outcomes such as mortality, stroke, and heart failure, particularly in the elderly, which has led some to advocate that DDD/R devices should never be offered to elderly AV block patients. However, we believe that the elderly, like the young, come in many “shapes and sizes” and individualized medicine compels us to consider each pacemaker candidate as unique. Implanting DDD/R devices in chronologically older, yet physiologically younger, patients is justifiable and good medical practice. Where right ventricular (RV) pacing is necessary and unavoidable, physicians should consider routinely placing RV leads on the RV mid- or outflow tract septum because these location are as good, if not better, for patients than the current practice of RV apical lead placement. In patients with AV block and asymptomatic yet moderate to severely depressed left ventricular systolic function, primary cardiac resynchronization therapy (CRT) should be strongly considered. Compelling clinical trial evidence does not yet exist to indicate that CRT should be the standard of care in patients with AV block and intact left ventricular systolic function. Right ventricular septal lead placement remains a reasonable option.

Keywords

Right Ventricular Cardiac Resynchronization Therapy Right Ventricular Outflow Tract Left Ventricular Lead Left Ventricular Reverse Remodel 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Disclosure

S. Modi has had travel and/or accommodation expenses covered by St. Jude, Boston Scientific, and Medtronic for attendance at Heart Rhythm Society meetings. A. Krahn’s institution has received grants from St. Jude Medical, Boston Scientific, and Medtronic, as well as payment for development of educational presentations. R. Yee has received consulting fees from and developed patents for Medtronic Inc. His institution has received a grant and payment for lectures from Medtronic of Canada.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Furman S, Schwedel JB. An intracardiac pacemaker for Stokes-Adams seizures. N Engl J Med. 1959;261:943–8.PubMedCrossRefGoogle Scholar
  2. 2.
    Epstein AE, DiMarco JP, Ellenbogen KA, Estes 3rd NA, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51(21):e1–62.PubMedCrossRefGoogle Scholar
  3. 3.
    Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J. 2007;28(18):2256–95.PubMedCrossRefGoogle Scholar
  4. 4.
    Brandt J, Anderson H, Fahraeus T, Schuller H. Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode. J Am Coll Cardiol. 1992;20(3):633–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Kristensen L, Nielsen JC, Pedersen AK, Mortensen PT, Andersen HR. AV block and changes in pacing mode during long-term follow-up of 399 consecutive patients with sick sinus syndrome treated with an AAI/AAIR pacemaker. Pacing Clin Electrophysiol. 2001;24(3):358–65.PubMedCrossRefGoogle Scholar
  6. 6.
    Hoijer CJ, Hoglund P, Schuller H, Brandt J. Single chamber atrial pacing: a realistic option in sinus node disease: a long-term follow-up study of 213 patients. Pacing Clin Electrophysiol. 2007;30(6):740–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Tripp IG, Armstrong GP, Stewart JT, Hood MA, Smith WM. Atrial pacing should be used more frequently in sinus node disease. Pacing Clin Electrophysiol. 2005;28(4):291–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Adachi M, Igawa O, Yano A, Miake J, Inoue Y, Ogura K, et al. Long-term reliability of AAI mode pacing in patients with sinus node dysfunction and low Wenckebach block rate. Europace. 2008;10(2):134–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Clarke KW, Connelly DT, Charles RG. Single chamber atrial pacing: an underused and cost-effective pacing modality in sinus node disease. Heart. 1998;80(4):387–9.PubMedGoogle Scholar
  10. 10.••
    Nielsen JC, Thomsen PE, Hojberg S, Moller M, Vesterlund T, Dalsgaard D, Mortensen LS, Nielsen T, Asklund M, Friis EV, Christensen PD, Simonsen EH, Eriksen UH, Jensen GV, Svendsen JH, Toff WD, Healey JS, Andersen HR. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J. 2011. This article presents preliminary data looking at AAI pacing in SAND patients.Google Scholar
  11. 11.
    Kristensen L, Nielsen JC, Mortensen PT, Pedersen OL, Pedersen AK, Andersen HR. Incidence of atrial fibrillation and thromboembolism in a randomised trial of atrial versus dual chamber pacing in 177 patients with sick sinus syndrome. Heart. 2004;90(6):661–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Fleischmann KE, Orav EJ, Lamas GA, Mangione CM, Schron EB, Lee KL, et al. Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST). Am Heart J. 2009;158(1):78–83, e72.PubMedCrossRefGoogle Scholar
  13. 13.
    Skanes AC, Krahn AD, Yee R, Klein GJ, Connolly SJ, Kerr CR, et al. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. CTOPP Investigators. J Am Coll Cardiol. 2001;38(1):167–72.PubMedCrossRefGoogle Scholar
  14. 14.
    Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D, et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med. 2007;357(10):1000–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Rediker DE, Eagle KA, Homma S, Gillam LD, Harthorne JW. Clinical and hemodynamic comparison of VVI versus DDD pacing in patients with DDD pacemakers. Am J Cardiol. 1988;61(4):323–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Taylor JA, Morillo CA, Eckberg DL, Ellenbogen KA. Higher sympathetic nerve activity during ventricular (VVI) than during dual-chamber (DDD) pacing. J Am Coll Cardiol. 1996;28(7):1753–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Oginosawa Y, Abe H, Yasumasu T, Tsurugi T, Kohno R. Comparison of the effects of VVI versus DDD pacing on cardiac baroreflex function. J Cardiovasc Electrophysiol. 2006;17(5):526–31.PubMedCrossRefGoogle Scholar
  18. 18.
    Vardas PE, Markianos M, Skalidis E, Simantirakis E, Manios E, Papavasiliou E. Twenty four hour variation in plasma atrial natriuretic factor during VVI and DDD pacing. Heart. 1996;75(6):620–2.PubMedCrossRefGoogle Scholar
  19. 19.
    Altun A, Erdogan O, Yildiz M. Acute effect of DDD versus VVI pacing on arterial distensibility. Cardiology. 2004;102(2):89–92.PubMedCrossRefGoogle Scholar
  20. 20.
    Kaszala K, Kalahasty G, Ellenbogen KA. Cardiac pacing in the elderly. Am J Geriatr Cardiol. 2006;15(2):77–81.PubMedCrossRefGoogle Scholar
  21. 21.
    Newman D, Lau C, Tang AS, Irvine J, Paquette M, Woodend K, et al. Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic Pacing. Am Heart J. 2003;145(3):430–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med. 2000;342(19):1385–91.PubMedCrossRefGoogle Scholar
  23. 23.
    Lamas GA, Orav EJ, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med. 1998;338(16):1097–104.PubMedCrossRefGoogle Scholar
  24. 24.
    Toff WD, Camm AJ, Skehan JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med. 2005;353(2):145–55.PubMedCrossRefGoogle Scholar
  25. 25.
    Channon KM, Hargreaves MR, Cripps TR, Gardner M, Ormerod OJ. DDD vs. VVI pacing in patients aged over 75 years with complete heart block: a double-blind crossover comparison. Q J Med. 1994;87(4):245–51.PubMedGoogle Scholar
  26. 26.
    Avery P, Banning A, Lawson T, McGurk L, Buchalter M. Physiological pacing improves symptoms and increases exercise capacity in the elderly patient. Int J Cardiol. 1994;46(2):129–33.PubMedCrossRefGoogle Scholar
  27. 27.
    Brady PA, Shen WK, Neubauer SA, Hammill SC, Hodge DO, Hayes DL. Pacing mode and long-term survival in elderly patients with congestive heart failure: 1980–1985. J Interv Card Electrophysiol. 1997;1(3):193–201.PubMedCrossRefGoogle Scholar
  28. 28.
    Ouali S, Neffeti E, Ghoul K, Hammas S, Kacem S, Gribaa R, et al. DDD versus VVIR pacing in patients, ages 70 and over, with complete heart block. Pacing Clin Electrophysiol. 2010;33(5):583–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Sulke N, Dritsas A, Bostock J, Wells A, Morris R, Sowton E. “Subclinical” pacemaker syndrome: a randomised study of symptom free patients with ventricular demand (VVI) pacemakers upgraded to dual chamber devices. Br Heart J. 1992;67(1):57–64.PubMedCrossRefGoogle Scholar
  30. 30.
    Schmidt B, Brunner M, Olschewski M, Hummel C, Faber TS, Grom A, et al. Pacemaker therapy in very elderly patients: long-term survival and prognostic parameters. Am Heart J. 2003;146(5):908–13.PubMedCrossRefGoogle Scholar
  31. 31.
    Hall MJ, DeFrances CJ, Williams SN, Golosinskiy A, Schwartzman A. National Hospital Discharge Survey: 2007 summary. Natl Health Stat Report. 2010;29:1–20, 24.PubMedGoogle Scholar
  32. 32.
    de Belder MA, Linker NJ, Jones S, Camm AJ, Ward DE. Cost implications of the British Pacing and Electrophysiology Group’s recommendations for pacing. BMJ. 1992;305(6858):861–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Wiegand UK, Potratz J, Bode F, Schreiber R, Bonnemeier H, Peters W, et al. Cost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block? Eur Heart J. 2001;22(2):174–80.PubMedCrossRefGoogle Scholar
  34. 34.
    Huang M, Krahn AD, Yee R, Klein GJ, Skanes AC. Optimal pacing for symptomatic AV block: a comparison of VDD and DDD pacing. Pacing Clin Electrophysiol. 2004;27(1):19–23.PubMedCrossRefGoogle Scholar
  35. 35.
    Durrer D, van Dam RT, Freud GE, Janse MJ, Meijler FL, Arzbaecher RC. Total excitation of the isolated human heart. Circulation. 1970;41(6):899–912.PubMedGoogle Scholar
  36. 36.
    Giudici MC, Karpawich PP. Alternative site pacing: it’s time to define terms. Pacing Clin Electrophysiol. 1999;22(4 Pt 1):551–3.PubMedCrossRefGoogle Scholar
  37. 37.
    Lieberman R, Grenz D, Mond HG, Gammage MD. Selective site pacing: defining and reaching the selected site. Pacing Clin Electrophysiol. 2004;27(6 Pt 2):883–6.PubMedCrossRefGoogle Scholar
  38. 38.
    Mond HG, Hillock RJ, Stevenson IH, McGavigan AD. The right ventricular outflow tract: the road to septal pacing. Pacing Clin Electrophysiol. 2007;30(4):482–91.PubMedCrossRefGoogle Scholar
  39. 39.
    Mond HG, Gammage MD. Selective site pacing: the future of cardiac pacing? Pacing Clin Electrophysiol. 2004;27(6 Pt 2):835–6.PubMedCrossRefGoogle Scholar
  40. 40.
    McGavigan AD, Roberts-Thomson KC, Hillock RJ, Stevenson IH, Mond HG. Right ventricular outflow tract pacing: radiographic and electrocardiographic correlates of lead position. Pacing Clin Electrophysiol. 2006;29(10):1063–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Rosso R, Teh AW, Medi C, Hung TT, Balasubramaniam R, Mond HG. Right ventricular septal pacing: the success of stylet-driven active-fixation leads. Pacing Clin Electrophysiol. 2010;33(1):49–53.PubMedCrossRefGoogle Scholar
  42. 42.
    Mond HG, Vlay SC. Pacing the right ventricular septum: time to abandon apical pacing. Pacing Clin Electrophysiol. 2010;33(11):1293–7.PubMedCrossRefGoogle Scholar
  43. 43.•
    Zanon F, Svetlich C, Occhetta E, Catanzariti D, Cantu F, Padeletti L, Santini M, Senatore G, Comisso J, Varbaro A, Denaro A, Sagone A. Safety and Performance of a System Specifically Designed for Selective Site Pacing. Pacing Clin Electrophysiol. 2010. This is an important study of technological advances in lead delivery.Google Scholar
  44. 44.
    Ng AC, Allman C, Vidaic J, Tie H, Hopkins AP, Leung DY. Long-term impact of right ventricular septal versus apical pacing on left ventricular synchrony and function in patients with second- or third-degree heart block. Am J Cardiol. 2009;103(8):1096–101.PubMedCrossRefGoogle Scholar
  45. 45.
    Medi C, Mond HG. Right ventricular outflow tract septal pacing: long-term follow-up of ventricular lead performance. Pacing Clin Electrophysiol. 2009;32(2):172–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Yee R, Klein GJ, Krahn AC, Skanes AC. Selective site pacing: tools and training. Pacing Clin Electrophysiol. 2004;27(6 Pt 2):894–6.PubMedCrossRefGoogle Scholar
  47. 47.
    Giudici MC, Thornburg GA, Buck DL, Coyne EP, Walton MC, Paul DL, et al. Comparison of right ventricular outflow tract and apical lead permanent pacing on cardiac output. Am J Cardiol. 1997;79(2):209–12.PubMedCrossRefGoogle Scholar
  48. 48.
    de Cock CC, Meyer A, Kamp O, Visser CA. Hemodynamic benefits of right ventricular outflow tract pacing: comparison with right ventricular apex pacing. Pacing Clin Electrophysiol. 1998;21(3):536–41.PubMedCrossRefGoogle Scholar
  49. 49.
    Leong DP, Mitchell AM, Salna I, Brooks AG, Sharma G, Lim HS, et al. Long-term mechanical consequences of permanent right ventricular pacing: effect of pacing site. J Cardiovasc Electrophysiol. 2010;21(10):1120–6.PubMedCrossRefGoogle Scholar
  50. 50.
    Flevari P, Leftheriotis D, Fountoulaki K, Panou F, Rigopoulos AG, Paraskevaidis I, et al. Long-term nonoutflow septal versus apical right ventricular pacing: relation to left ventricular dyssynchrony. Pacing Clin Electrophysiol. 2009;32(3):354–62.PubMedCrossRefGoogle Scholar
  51. 51.
    Kypta A, Steinwender C, Kammler J, Leisch F, Hofmann R. Long-term outcomes in patients with atrioventricular block undergoing septal ventricular lead implantation compared with standard apical pacing. Europace. 2008;10(5):574–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Tse HF, Yu C, Wong KK, Tsang V, Leung YL, Ho WY, et al. Functional abnormalities in patients with permanent right ventricular pacing: the effect of sites of electrical stimulation. J Am Coll Cardiol. 2002;40(8):1451–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288(24):3115–23.PubMedCrossRefGoogle Scholar
  54. 54.
    Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node (MOST)dysfunction. Circulation. 2003;107(23):2932–7.PubMedCrossRefGoogle Scholar
  55. 55.••
    Kaye G, Stambler BS, Yee R. Search for the optimal right ventricular pacing site: design and implementation of three randomized multicenter clinical trials. Pacing Clin Electrophysiol. 2009;32(4):426–33. This article explains the preliminary design of three major upcoming trials comparing septal versus apical RV pacing.Google Scholar
  56. 56.
    Katsivas A, Manolis AG, Lazaris E, Vassilopoulos C, Louvros N. Atrial septal pacing to synchronize atrial depolarization in patients with delayed interatrial conduction. Pacing Clin Electrophysiol. 1998;21(11 Pt 2):2220–5.PubMedCrossRefGoogle Scholar
  57. 57.
    Friedman PA, Hill MR, Hammill SC, Hayes DL, Stanton MS. Randomized prospective pilot study of long-term dual-site atrial pacing for prevention of atrial fibrillation. Mayo Clin Proc. 1998;73(9):848–54.PubMedCrossRefGoogle Scholar
  58. 58.
    Spencer 3rd WH, Zhu DW, Markowitz T, Badruddin SM, Zoghbi WA. Atrial septal pacing: a method for pacing both atria simultaneously. Pacing Clin Electrophysiol. 1997;20(11):2739–45.PubMedCrossRefGoogle Scholar
  59. 59.
    Bailin SJ, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann’s bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol. 2001;12(8):912–7.PubMedCrossRefGoogle Scholar
  60. 60.
    Padeletti L, Pieragnoli P, Ciapetti C, Colella A, Musilli N, Porciani MC, et al. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J. 2001;142(6):1047–55.PubMedCrossRefGoogle Scholar
  61. 61.
    Hermida JS, Kubala M, Lescure FX, Delonca J, Clerc J, Otmani A, et al. Atrial septal pacing to prevent atrial fibrillation in patients with sinus node dysfunction: results of a randomized controlled study. Am Heart J. 2004;148(2):312–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Padeletti L, Porciani MC, Ritter P, Michelucci A, Colella A, Pieragnoli P, et al. Atrioventricular interval optimization in the right atrial appendage and interatrial septum pacing: a comparison between echo and peak endocardial acceleration measurements. Pacing Clin Electrophysiol. 2000;23(11 Pt 1):1618–22.PubMedCrossRefGoogle Scholar
  63. 63.
    Kindermann M, Schwaab B, Berg M, Frohlig G. The influence of right atrial septal pacing on the interatrial contraction sequence. Pacing Clin Electrophysiol. 2000;23(11 Pt 2):1752–7.PubMedGoogle Scholar
  64. 64.
    Porciani MC, Sabini A, Colella A, Michelucci A, Musilli N, Pieragnoli P, et al. Interatrial septum pacing avoids the adverse effect of interatrial delay in biventricular pacing: an echo-Doppler evaluation. Europace. 2002;4(3):317–24.PubMedCrossRefGoogle Scholar
  65. 65.
    Di Pede F, Gasparini G, De Piccoli B, Yu Y, Cuesta F, Raviele A. Hemodynamic effects of atrial septal pacing in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol. 2005;16(12):1273–8.PubMedCrossRefGoogle Scholar
  66. 66.
    Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure (CARE-HF). N Engl J Med. 2005;352(15):1539–49.PubMedCrossRefGoogle Scholar
  67. 67.
    Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140–50.PubMedCrossRefGoogle Scholar
  68. 68.
    Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344(12):873–80.PubMedCrossRefGoogle Scholar
  69. 69.
    Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346(24):1845–53.PubMedCrossRefGoogle Scholar
  70. 70.
    Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, et al. Cardiac resynchronization in chronic heart failure (MIRACLE). N Engl J Med. 2002;346(24):1845–53.PubMedCrossRefGoogle Scholar
  71. 71.•
    Abraham WT, Gras D, Yu CM, Guzzo L, Gupta MS. Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial. Am Heart J. 2010;159(6):944–8 e941. This is an important trial looking at electrical optimization methods and response.Google Scholar
  72. 72.•
    Rickard J, Kumbhani DJ, Popovic Z, Verhaert D, Manne M, Sraow D, Baranowski B, Martin DO, Lindsay BD, Grimm RA, Wilkoff BL, Tchou P. Characterization of super-response to cardiac resynchronization therapy. Heart Rhythm. 2010;7(7):885–9. This is an interesting trial reporting a new phenomenon in CRT.Google Scholar
  73. 73.
    Linde C, Gold M, Abraham WT, Daubert JC. Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) study. Congest Heart Fail. 2008;14(2):66–74.PubMedCrossRefGoogle Scholar
  74. 74.•
    Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Torok T, Linde C. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol. 2009;54(20):1837–46. This is the first of a series of trials looking at expanding the role of CRT in minimally symptomatic heart failure.Google Scholar
  75. 75.•
    Linde C, Mealing S, Hawkins N, Eaton J, Brown B, Daubert JC. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction). Eur Heart J. 2010. This is an important substudy of the REVERSE trial looking at cost efficiacy of CRT in minimally symptomatic heart failure.Google Scholar
  76. 76.
    Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, et al. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation. 2010;122(10):985–92.PubMedCrossRefGoogle Scholar
  77. 77.••
    Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL. Cardiac-resynchronization therapy for mild-to-moderate heart failure (RAFT). N Engl J Med. 2010;363(25):2385–95. This is an important prospective trial of CRT in NYHA class II patients showing both a symptom and mortality benefit.Google Scholar
  78. 78.
    Boerrigter G, Costello-Boerrigter LC, Abraham WT, Sutton MG, Heublein DM, Kruger KM, et al. Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate. J Card Fail. 2008;14(7):539–46.PubMedCrossRefGoogle Scholar
  79. 79.
    Adelstein EC, Shalaby A, Saba S. Response to cardiac resynchronization therapy in patients with heart failure and renal insufficiency. Pacing Clin Electrophysiol. 2010;33(7):850–9.PubMedCrossRefGoogle Scholar
  80. 80.••
    Goldenberg I, Moss AJ, McNitt S, Barsheshet A, Gray D, Andrews ML, Brown MW, Zareba W, Sze E, Solomon SD, Pfeffer MA. Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Heart Rhythm. 2010;7(12):1777–82. This is an important substudy of the MADIT-CRT trial assessing renal dysfunction in CRT.Google Scholar
  81. 81.
    Doshi RN, Daoud EG, Fellows C, Turk K, Duran A, Hamdan MH, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol. 2005;16(11):1160–5.PubMedCrossRefGoogle Scholar
  82. 82.
    Kindermann M, Hennen B, Jung J, Geisel J, Bohm M, Frohlig G. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE). J Am Coll Cardiol. 2006;47(10):1927–37.PubMedCrossRefGoogle Scholar
  83. 83.
    Orlov MV, Gardin JM, Slawsky M, Bess RL, Cohen G, Bailey W, et al. Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation. Am Heart J. 2010;159(2):264–70.PubMedCrossRefGoogle Scholar
  84. 84.
    Paparella G, Sciarra L, Capulzini L, Francesconi A, De Asmundis C, Sarkozy A, et al. Long-term effects of upgrading to biventricular pacing: differences with cardiac resynchronization therapy as primary indication. Pacing Clin Electrophysiol. 2010;33(7):841–9.PubMedCrossRefGoogle Scholar
  85. 85.
    Yu CM, Chan JY, Zhang Q, Omar R, Yip GW, Hussin A, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction (PACE). N Engl J Med. 2009;361(22):2123–34.PubMedCrossRefGoogle Scholar
  86. 86.•
    Nazeri A, Massumi A, Rasekh A, Saeed M, Frank C, Razavi M. Cardiac resynchronization therapy in patients with right ventricular pacing-induced cardiomyopathy. Pacing Clin Electrophysiol. 2010;33(1):37–40. This is a small but informative study looking at clinical improvement in LV lead upgrades in RV-paced patients who develop a pacing-related cardiomyopathy.Google Scholar
  87. 87.••
    Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, Shinn T, Dan D, Feldman LA, Seide H, Winston SA, Gallagher JJ, Langberg JJ, Mitchell K, Holcomb R. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010;122(16):1553–61. This is an important study detailing the risks of device and lead upgrade procedures.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Arrhythmia ServiceLondon Health Sciences CentreLondonCanada

Personalised recommendations